Authors
Muhammad Adnan Akhtar, Syed Abdul Nafay Ali, Manaal Hasib, Ariba Murtaza, Maha Masood Usmani, Bushra Tabassum, Nayab Magsi, Waqar Ali, Kanza Farhan
Published in
Molecular biology reports. Volume 53. Issue 1. Nov 15, 2026. Epub Nov 15, 2026.
Abstract
Regulatory T cells (Tregs) maintain peripheral immune tolerance, with FOXP3 directing much of their differentiation and suppressive activity. Pathogenic FOXP3 variants cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Although often described as Treg deficiency, IPEX can occur despite preserved circulating Treg numbers and detectable FOXP3 expression. This narrative review examines how FOXP3 variants disrupt regulatory function and compares IPEX with selected genetic disorders involving BACH2, IL2RA, STAT5B, CTLA4 or LRBA. Structural and epigenetic findings are considered alongside their implications for diagnosis and treatment. The disorders are grouped by transcriptional regulation, IL-2-dependent homeostasis and checkpoint function; an IPEX-like presentation is distinguished from a defined Tregopathy. Genetic testing is central to diagnosis, while immunophenotyping and selected functional or epigenetic studies provide supporting evidence. In severe disease, investigation, stabilization and hematopoietic stem cell transplantation (HSCT) assessment should proceed together. HSCT remains an established potentially curative treatment. Cellular and genetic therapies are at different stages of development, from preclinical studies to early human investigation, and must be assessed individually. Comparisons with other genetic disorders and common autoimmunity help explain shared biology, but treatment findings cannot be assumed to apply equally to IPEX.
PMID:
43034965
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 11
- Comments 0